FEATURED SLIDESHOW
Who Is The Worst CEO?Mad Money needed new inductees for its
Wall of Shame, so we asked viewers for
nominations.
RECENT POSTS
- Time to Buy Treasurys?
- Lightning Round: Las Vegas Sands, ADC Telecom, Satyam Computer and More
- Lightning Round OT: Knight Capital, Ebix and More
- Is Lear, Back From Bankruptcy, a Buy?
- Sanofi-Aventis Falling Off a Patent Cliff?
- Cramer: Your Thanksgiving Week Game Plan
- Cramer: Next Week Should Define Rest of ‘09
- Mad Money: Mad Mail: Buy RIM or Apple?
- Lightning Round: Cisco Systems, Citigroup, Baidu.com and More
- Lightning Round OT: Martek Biosciences, Valmont Industries and More
MAD MONEY FEATURES
PODCASTSWatch the Lightning Round whenever and wherever you want.
OFFICIAL MAD MONEY WIDGETGrab this all-in-one application and get recaps of the show sent right to your desktop or blog.
CRAMERS SOUNDBOARDAdmit it: You've always wanted to hit the "They
know nothing!" button. Here’s your chance.
CHECK OUT OUR PHOTOSCheck out Cramer on set, back to school, behind the scenes and more.
SHOP FOR MAD MERCHANDISEBuy Cramer books, bobbleheads and other Mad Money merchandise.
RING TONESPick up the phone! It's Cramer! New Mad Money sounds for your cell phone.
TEXT MESSAGE ALERTMad Money's mobile. Get show highlights sent to your phone.
Text Size 
With all the trouble in oil, largely due to unchecked speculation, the market has just lost one of its key drivers over the past few months. The triple threat of oil, banks and tech has gotten a bit less threatening as a result, and Wall Street needs to find another sector to take up the flag. Cramer thinks he’s found it in health care.
That’s right, health care. The very industry that President Obama’s reform-minded administration has had in its sites. The uncertainty about what could happen, about which companies would suffer most, caused a sell-off in the group’s stocks, and probably with good reason. But now that we have a better idea of what the White House has planned, some of these companies can be had on the cheap.
What do we know? Obama hates waste. So the businesses that cut costs, save money and boost efficiency will be favored. That’s why Cramer likes MedcoHealth Solutions [MOS
Loading...
()
], Quest Diagnostics [MOS
Loading...
()
] and Allscripts-Misys Healthcare Solutions [MOS
Loading...
()
].
Medco saves both companies and consumers money by selling drugs in bulk, a business that offers consistent earnings and significant growth. If health care does replace oil as a market leader, which Cramer expects, this stock could jump to $60 from $46.
Quest and Allscripts generate plenty of savings as well. The former catches diseases and other medical conditions early through testing, while the latter digitizes medical records and prescription writing. Both should do well under Obama, Cramer said.
Elsewhere in health care, Cramer likes device markers St. Jude Medical [MOS
Loading...
()
] on the high end and Boston Scientific [MOS
Loading...
()
] on the low end. Like Medco, STJ is known for its consistency, and BSX is showing signs of a turnaround.
For drug companies, Cramer endorsed Gilead Sciences [MOS
Loading...
()
] for its AIDS treatments and Abbott Labs [MOS
Loading...
()
] for its growth. He thinks GILD could report an upside surprise next quarter.
Health care also offers something oil cannot: long-term growth, even in a slowdown. With the impending doom of Obama’s possible changes now in the past, this sector should be on track to deliver that.
Health care, tech and financials fueled the 1990s bull market, Cramer said, and he thinks the trio could do it again.
Cramer's charitable trust owns Abbott Labs and Gilead Sciences.
Call Cramer: 1-800-743-CNBC
Questions for Cramer?
Questions, comments, suggestions for the Mad Money website?
Data is a real-time snapshot *Data is delayed at least 15 minutes